Hyponatraemia in heart failure: time for new solutions?
Abstract
Hyponatraemia is very common in heart failure (HF), especially in decompensated patients. It is associated with increased mortality and morbidity and considered a marker of advanced disease. Recognition of hyponatraemia and its causes may help guide treatment strategy. Historically, therapy has primarily focused on water restriction, decongestion with loop diuretics in case of volume overload (dilutional hyponatraemia) and sodium repletion in case of depletion. In this review, we summarise the potential benefits of established and emerging HF therapies on sodium homeostasis, with a focus on dual vasopressin antagonists, angiotensin receptor-neprilysin inhibitors, sodium-glucose cotransporter 2 inhibitors and hypertonic saline, and propose a potential therapeutic approach for hyponatraemia in HF.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (agreement #075-15-2020-800)
- the Special Research Fund (BOF) of Hasselt University (BOF19PD04)
This publication has 47 references indexed in Scilit:
- The Kidney in Congestive Heart Failure: ‘are Natriuresis, Sodium, and Diuretics Really the Good, the Bad and the Ugly?’European Journal of Heart Failure, 2013
- 2013 ACCF/AHA Guideline for the Management of Heart FailureCirculation, 2013
- Clinical Course of Patients With Hyponatremia and Decompensated Systolic Heart Failure and the Effect of Vasopressin Receptor Antagonism With TolvaptanJournal of Cardiac Failure, 2013
- Intravenous High-Dose Furosemide and Hypertonic Saline Solutions for Refractory Heart Failure and AscitesSeminars in Nephrology, 2011
- Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)The American Journal of the Medical Sciences, 2011
- Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart FailureThe EVEREST Outcome TrialJAMA, 2007
- Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registryEuropean Heart Journal, 2007
- The Seattle Heart Failure ModelCirculation, 2006
- Renal Prostaglandin Synthesis and Angiotensin-Converting Enzyme InhibitionJournal of Cardiovascular Pharmacology, 1992
- EFFECTS OF ACE INHIBITION ON RENAL REGULATION OF SALT AND WATERActa Medica Scandinavica, 1986